- Home
- PSTX vs CHI Comparison
PSTX vs CHI Comparison
Compare PSTX & CHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTX
- CHI
- Stock Information
- Founded
- PSTX 2014
- CHI 2002
- Country
- PSTX United States
- CHI United States
- Employees
- PSTX N/A
- CHI N/A
- Industry
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- CHI Investment Managers
- Sector
- PSTX Health Care
- CHI Finance
- Exchange
- PSTX Nasdaq
- CHI Nasdaq
- Market Cap
- PSTX 909.4M
- CHI 910.4M
- IPO Year
- PSTX 2020
- CHI N/A
- Fundamental
- Price
- PSTX $9.45
- CHI $12.00
- Analyst Decision
- PSTX Hold
- CHI
- Analyst Count
- PSTX 3
- CHI 0
- Target Price
- PSTX $9.00
- CHI N/A
- AVG Volume (30 Days)
- PSTX 2.7M
- CHI 186.2K
- Earning Date
- PSTX 11-07-2024
- CHI 01-01-0001
- Dividend Yield
- PSTX N/A
- CHI 9.90%
- EPS Growth
- PSTX N/A
- CHI N/A
- EPS
- PSTX N/A
- CHI N/A
- Revenue
- PSTX $150,858,000.00
- CHI N/A
- Revenue This Year
- PSTX $131.92
- CHI N/A
- Revenue Next Year
- PSTX N/A
- CHI N/A
- P/E Ratio
- PSTX N/A
- CHI N/A
- Revenue Growth
- PSTX 203.18
- CHI N/A
- 52 Week Low
- PSTX $1.87
- CHI $9.70
- 52 Week High
- PSTX $9.58
- CHI $11.61
- Technical
- Relative Strength Index (RSI)
- PSTX 86.05
- CHI 51.53
- Support Level
- PSTX $9.35
- CHI $11.70
- Resistance Level
- PSTX $9.56
- CHI $12.19
- Average True Range (ATR)
- PSTX 0.10
- CHI 0.19
- MACD
- PSTX -0.17
- CHI -0.04
- Stochastic Oscillator
- PSTX 56.67
- CHI 47.62
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.
About CHI Calamos Convertible Opportunities and Income Fund
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND operates as a closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in convertible securities and high-yield securities.